John Colucci

USPTO Granted Patents = 23 (Patent Applications = 1)

CIPO Patents = 4

EPO Patents = 11 (Patent Applications = 4)

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 71(Granted Patents)

Location History:

Westmount, CA (2002 - 2006)
Kirkland, CA (2006 - 2021)

Company Filing History:

Merck Frosst Canada, Inc.

Debiopharm International, S.a.

patents

7. 2 out of 2,405

Merck Sharp + Dohme Corp.

patents

8. 1 out of 76

Merck Frosst Canada & Co.

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12213987 - Prodrug salts (2025-02-04),

2. 11071744 - Prodrug salts (2021-07-27),

3. 10258636 - Prodrug salts (2019-04-16),

4. 10035813 - Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2018-07-31),

5. 9827253 - Prodrug salts (2017-11-28),

6. 9334295 - Fused aromatic PTP-1B inhibitors (2016-05-10),

7. 9023864 - Indole derivatives as CRTH2 receptor antagonists (2015-05-05),

8. 8927526 - Fused aromatic PTP-1B inhibitors (2015-01-06),

9. 8901105 - Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide (2014-12-02),

10. 8637671 - Indole derivatives as CRTH2 receptor antagonists (2014-01-28),

11. 8481742 - Fused aromatic PTP-1B inhibitors (2013-07-09),

12. 8394819 - Indole derivatives as CRTH2 receptor antagonists (2013-03-12),

13. 8168815 - Fused aromatic PTP-1B inhibitors (2012-05-01),

14. 8158671 - Indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists (2012-04-17),

15. 8013159 - Quinoline derivatives as EP4 antagonists (2011-09-06),

Title: Innovator Spotlight: John Colucci's Groundbreaking Patents and Career Achievements

Introduction:

Throughout his illustrious career, John Colucci has continuously pursued innovative solutions to long-standing problems, earning him tremendous recognition and numerous milestones. His groundbreaking inventions have not only enhanced existing technologies but have also introduced novel advancements across various fields. In this spotlight article, we delve into his latest patents, career highlights, notable collaborations, and the remarkable contributions that have cemented Colucci as a remarkable innovator.

Latest Patents:

Among John Colucci's recent patents, a key highlight is his invention of novel prodrug salts of selective aquaporin inhibitors. These patents detail the use of these compounds as pharmaceuticals for treating and controlling aquaporin-mediated conditions, such as edema, hyponatremia, migraines, and several other diseases associated with water imbalance. The innovative compositions and synthesis processes presented in these patents signify significant advancements in the field of medical research and solution-focused drug development.

Career Highlights:

Colucci's career has been nothing short of exceptional, marked by numerous accomplishments and transformative contributions. Having worked with esteemed organizations such as Merck Frosst Canada, Inc. and Merck Canada Inc., he has consistently demonstrated a commitment to pushing boundaries and tackling scientific challenges head-on. His dedication to improving existing technologies and introducing novel solutions has undoubtedly made a lasting impact in the field of pharmaceutical research and development.

Collaborations:

Throughout his career, John Colucci has collaborated with a variety of accomplished professionals, further expanding the scope of his innovative endeavors. Notable collaborations include working closely with researchers such as Yongxin Han and Marie-Claire Wilson. These collaborations have undoubtedly enriched his work, fostering a diverse range of perspectives and insights that have contributed to the success of Colucci's inventions.

Conclusion:

John Colucci's remarkable career and exceptional patent portfolio are a testament to his unwavering dedication to advancing the boundaries of innovation. From his groundbreaking patents in the field of aquaporin inhibitors to his collaborations with esteemed researchers, Colucci has consistently demonstrated his ability to deliver novel solutions to pressing problems. His inventive mindset and quest for progress continue to shape the landscape of medical research and development. It is individuals like John Colucci who propel us towards a future fueled by innovation and ingenuity.

For more information on John Colucci's patents, career, and other noteworthy inventors and innovations, visit our website at iDiyas.com.

This text is generated by artificial intelligence and may not be accurate.